Imipenem/cilastatin treatment of bacterial meningitis in children
about
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infantsImipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effectsRandomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study GroupSafety profile of meropenem: a review of nearly 5,000 patients treated with meropenemPediatric anthrax clinical managementTherapy of experimental meningitis due to Salmonella enteritidis.Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children witEpileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.Current pharmacotherapy of pneumococcal meningitis.Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant.Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.Neurotoxic effects associated with antibiotic use: management considerationsCefotaxime breakpoint for Streptococcus pneumoniae.In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.Epileptogenic drugs: a systematic review.An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in?Safety of imipenem/cilastatin in neurocritical care patients.Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review.Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats.Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluidTherapy of penicillin- and cephalosporin-resistant pneumococcal infections.The risk of seizures among the carbapenems: a meta-analysis.Ertapenem-Induced Encephalopathy in a Patient With Normal Renal FunctionTreatment of Serratia marcescens meningitis with prolonged infusion of meropenem.Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistant Escherichia coli.
P2860
Q24601509-8A34F7FB-9BBE-4DD6-8477-E71D5BC2B496Q28260317-6D5F4381-213D-4EE2-A3AA-1AA5628EBAC7Q28367896-22701394-D13C-4A40-89B5-D8DCFBEAE0D6Q28378163-9CC0545D-BF13-4BBC-AFD0-DF7126EBE821Q28397091-28794F79-A183-435F-88B3-FC097C328541Q30433367-393F6C31-7C59-4A4F-BB3D-98310008E59AQ31462845-B622F07C-7939-47D8-A0E9-499A2E2EAC3FQ33692927-9CAF1BD3-F01A-4718-9A53-775D8CD066B7Q34026343-D56D0477-0017-4D83-BF07-E9F4F230CC62Q34142328-A697217E-DEFD-4569-B7DA-B4196A625A5DQ34519236-438F4394-CB97-4286-9D30-DB6F423101C0Q34788854-222A01F5-CF6B-4D18-BF91-8673398E0D2AQ35119049-FB02E1C7-F1ED-4A19-B05F-FC55E822029CQ35219637-2A6E4643-C9DA-43CE-9668-B054D4931A63Q35810802-79A0AFD6-9DC2-49C6-8105-B3302347C75DQ35822592-9426EF73-BA49-4F1E-80C5-D1C5D904C25BQ36453297-A1A27A71-08C4-4666-8798-17B0B027D69DQ36667925-AE6D7C20-A333-4775-8456-00C4BDE3974AQ37360448-6AD9A57F-F4E7-4816-9FF4-4F294A04ECD1Q38093135-6EB7A9E2-5EB2-4A59-90D8-307D6F30A59DQ38654209-9A0A6145-DBEC-48FD-AE8C-A40103514A35Q39477395-CB4BA09F-2A63-44B0-9147-5E96A458FEE1Q40600560-0205DD55-9D35-4E2E-A5A2-E9049E20E7FDQ40785357-8659BCD9-2CD0-4768-9800-2D43EEBF115BQ42218823-74719269-C94B-4020-9203-68E8CF67A02BQ42323100-5D54B132-352B-4956-95C4-3C6AEBF7E53FQ51754688-54F100AE-0423-4962-B787-07DFF80BF92DQ52034877-CDA815D9-B7D1-4F2A-B778-E32E56EADAC5
P2860
Imipenem/cilastatin treatment of bacterial meningitis in children
description
1991 nî lūn-bûn
@nan
1991 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Imipenem/cilastatin treatment of bacterial meningitis in children
@ast
Imipenem/cilastatin treatment of bacterial meningitis in children
@en
Imipenem/cilastatin treatment of bacterial meningitis in children
@nl
type
label
Imipenem/cilastatin treatment of bacterial meningitis in children
@ast
Imipenem/cilastatin treatment of bacterial meningitis in children
@en
Imipenem/cilastatin treatment of bacterial meningitis in children
@nl
prefLabel
Imipenem/cilastatin treatment of bacterial meningitis in children
@ast
Imipenem/cilastatin treatment of bacterial meningitis in children
@en
Imipenem/cilastatin treatment of bacterial meningitis in children
@nl
P2093
P1476
Imipenem/cilastatin treatment of bacterial meningitis in children
@en
P2093
P356
10.1097/00006454-199102000-00009
P407
P577
1991-02-01T00:00:00Z